Cargando…

Angiogenic profile identifies pulmonary hypertension in children with Down syndrome

Past studies have shown that lung angiogenic signaling may be abnormal in children with Down syndrome, but whether differences in circulating angiogenic proteins can identify pulmonary hypertension in children with Down syndrome is unknown. A prospective study of 78 children from birth to 21 years o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bush, Douglas, Wolter-Warmerdam, Kristine, Wagner, Brandie D., Galambos, Csaba, Ivy, D.Dunbar, Abman, Steven H., McMorrow, Deven, Hickey, Francis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696852/ https://www.ncbi.nlm.nih.gov/pubmed/31293212 http://dx.doi.org/10.1177/2045894019866549

Ejemplares similares

Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension
por: Galambos, Csaba, et al.
Publicado: (2016)

Pulmonary Hypertension in the Population with Down Syndrome
por: Bush, Douglas S., et al.
Publicado: (2022)

Intrapulmonary bronchopulmonary anastomoses in COVID-19 respiratory failure
por: Galambos, Csaba, et al.
Publicado: (2021)

Microvascular Shunts in COVID-19 Pneumonia
por: Bush, Douglas, et al.
Publicado: (2022)

Infantile Spasms in Children With Down Syndrome: Identification and Treatment Response
por: Daniels, Dee, et al.
Publicado: (2019)

Evaluation of Circulating Proteins and Hemodynamics Towards Predicting Mortality in Children with Pulmonary Arterial Hypertension
por: Wagner, Brandie D., et al.
Publicado: (2013)

Circulating Cytokines and Growth Factors in Pediatric Pulmonary Hypertension
por: Duncan, Mark, et al.
Publicado: (2012)

Practice patterns of pulmonary hypertension secondary to left heart disease among pediatric pulmonary hypertension providers
por: Nawaytou, Hythem, et al.
Publicado: (2021)

IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndrome
por: Araya, Paula, et al.
Publicado: (2022)

Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management
por: Rosenzweig, Erika B., et al.
Publicado: (2019)

Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources
por: Geva, Alon, et al.
Publicado: (2019)

Echocardiography in Pediatric Pulmonary Hypertension
por: Jone, Pei-Ni, et al.
Publicado: (2014)

Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children
por: Frank, Benjamin S., et al.
Publicado: (2018)

Airway Microbial Community Turnover Differs by BPD Severity in Ventilated Preterm Infants
por: Wagner, Brandie D., et al.
Publicado: (2017)

Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation
por: Sullivan, Kelly D., et al.
Publicado: (2017)

Intrapulmonary Bronchopulmonary Anastomoses in Severe COVID-19–related Acute Respiratory Failure
por: Bodmer, Jenna, et al.
Publicado: (2022)

Arterial Hypertension Is Characterized by Imbalance of Pro-Angiogenic versus Anti-Angiogenic Factors
por: Marek-Trzonkowska, Natalia, et al.
Publicado: (2015)

Impaired NO-cGMP signaling in the pathogenesis of neonatal pulmonary hypertension and therapeutic implications
por: Abman, Steve H
Publicado: (2009)

Novel use of riociguat in infants with severe pulmonary arterial hypertension unable to wean from inhaled nitric oxide
por: Domingo, L. T., et al.
Publicado: (2022)

Segmental Pulmonary Hypertension in Children with Congenital Heart Disease
por: Das, Bibhuti B., et al.
Publicado: (2020)

Magnetic resonance phase contrast imaging in children with pulmonary artery hypertension
por: Fonseca, Brian, et al.
Publicado: (2009)

High‐level gonosomal mosaicism for a pathogenic non‐coding CNV deletion of the lung‐specific FOXF1 enhancer in an unaffected mother of an infant with ACDMPV
por: Yıldız Bölükbaşı, Esra, et al.
Publicado: (2022)

A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011
por: del Cerro, Maria Jesus, et al.
Publicado: (2011)

Maternal plasma angiogenic and inflammatory factor profiling in foetal Down syndrome
por: Zbucka-Kretowska, Monika, et al.
Publicado: (2017)

Of Registries and Disease Classification: Unmasking the Challenges of Pediatric Pulmonary Hypertension
por: Abman, Steven H., et al.
Publicado: (2022)

Treatment of pediatric pulmonary arterial hypertension: A focus on the NO‐sGC‐cGMP pathway
por: Beghetti, Maurice, et al.
Publicado: (2019)

Short‐Term Effects of Inhaled Nitric Oxide on Right Ventricular Flow Hemodynamics by 4‐Dimensional–Flow Magnetic Resonance Imaging in Children With Pulmonary Arterial Hypertension
por: Schäfer, Michal, et al.
Publicado: (2021)

Levodopa-Responsive Early-Onset Parkinsonism in Down Syndrome
por: Palat, Padmini, et al.
Publicado: (2018)

The Relationship of Novel Plasma Proteins in the Early Neonatal Period With Retinopathy of Prematurity
por: Lynch, Anne M., et al.
Publicado: (2016)

Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension
por: Barst, Robyn J., et al.
Publicado: (2012)

Prognostic Value of Angiogenic Markers in Pregnant Women With Chronic Hypertension
por: Binder, Julia, et al.
Publicado: (2021)

Hypertension in cancer patients treated with anti-angiogenic based regimens
por: Wasserstrum, Yishay, et al.
Publicado: (2015)

Activation of the unfolded protein response is associated with pulmonary hypertension
por: Yeager, Michael E., et al.
Publicado: (2012)

Left ventricular torsion rate and the relation to right ventricular function in pediatric pulmonary arterial hypertension
por: Dufva, Melanie J., et al.
Publicado: (2018)

Biomarkers for Pediatric Pulmonary Arterial Hypertension – A Call to Collaborate
por: Colvin, Kelley L., et al.
Publicado: (2014)

Methods of Weaning Preterm Babies <30 weeks Off CPAP: A Multicenter Randomized Controlled Trial
por: McMorrow, Aoife, et al.
Publicado: (2012)

Managing hyperglycemia during the COVID-19 pandemic: Improving outcomes using new technologies in intensive care
por: Valk, Timothy, et al.
Publicado: (2020)

Evidence from a Longitudinal Photovoice and Interview Assessment with Congolese Refugee Women in the Midwestern United States
por: McMorrow, Shannon, et al.
Publicado: (2021)

Unexpectedly durable palliation of metastatic olfactory neuroblastoma using anti-angiogenic therapy with Bevacizumab
por: Dunbar, Erin M., et al.
Publicado: (2012)

Myocardial Hypertrophy Overrides the Angiogenic Response to Hypoxia
por: Choi, Yeong-Hoon, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_kn4dd2i7k2lcj8hl2r34slrs38